Assessment of blood-retinal barrier integrity
- PMID: 7756735
Assessment of blood-retinal barrier integrity
Abstract
The blood-retinal barrier consists of two components which are comprised of the retinal vascular endothelium and the retinal pigment epithelium, respectively. Its functional integrity can be recognized by tight junctions between these cells with a paucity of endocytic vesicles within them and the presence of the molecules that regulate the ionic and metabolic gradients that constitute the barrier. The barrier is compromised in several disease processes and by a variety of agents, but in most cases the location and mechanism for barrier failure is not understood. Perfusion with a variety of radiolabeled tracer molecules, vitreous fluorophotometry, or magnetic resonance imaging can be used to quantitate blood-retinal barrier leakage. Fluorescein angiography or magnetic resonance imaging can localize sites of leakage in vivo with limited resolution. Evans blue dye can be used to visualize blood-retinal barrier failure in gross pathological specimens and immuno-histochemical labeling of serum proteins such as albumin or fibrinogen can be used to localize sites of blood-retinal barrier breakdown by light microscopy. Tracers such as horseradish peroxidase, microperoxidase, or lanthanum, or the immunocytochemical demonstration of albumin can be used to reveal blood-retinal barrier breakdown at the ultrastructural level and provide insights into the mechanisms involved. This review discusses the advantages and limitations of each of these methods to aid in selection of the appropriate techniques to derive the desired information.
Similar articles
-
The blood-retinal barrier in experimental autoimmune uveoretinitis. Leukocyte interactions and functional damage.Lab Invest. 1994 Jan;70(1):39-52. Lab Invest. 1994. PMID: 8302017
-
Electron microscopic immunocytochemical evidence for the mechanism of blood-retinal barrier breakdown in galactosemic rats and its association with aldose reductase expression and inhibition.Exp Eye Res. 1993 Dec;57(6):723-35. doi: 10.1006/exer.1993.1180. Exp Eye Res. 1993. PMID: 8150024
-
Blue-light-induced dysfunction of the blood-retinal barrier at the pigment epithelium in albino versus pigmented rabbits.Exp Eye Res. 1994 Jan;58(1):31-40. doi: 10.1006/exer.1994.1192. Exp Eye Res. 1994. PMID: 8157099
-
The blood-retinal barrier: structure and functional significance.Methods Mol Biol. 2011;686:133-48. doi: 10.1007/978-1-60761-938-3_5. Methods Mol Biol. 2011. PMID: 21082369 Review.
-
Fluid movement across the blood-retinal barrier: a review of studies by vitreous fluorophotometry.Jpn J Ophthalmol. 1990;34(2):133-41. Jpn J Ophthalmol. 1990. PMID: 2214357 Review.
Cited by
-
Layer-specific anatomical, physiological and functional MRI of the retina.NMR Biomed. 2008 Nov;21(9):978-96. doi: 10.1002/nbm.1311. NMR Biomed. 2008. PMID: 18792422 Free PMC article. Review.
-
Pazopanib, a multitargeted tyrosine kinase inhibitor, reduces diabetic retinal vascular leukostasis and leakage.Microvasc Res. 2011 Nov;82(3):346-50. doi: 10.1016/j.mvr.2011.09.001. Epub 2011 Sep 16. Microvasc Res. 2011. PMID: 21945644 Free PMC article.
-
Retinal layer assessments as potential biomarkers for brain atrophy in the Rhineland Study.Sci Rep. 2022 Feb 17;12(1):2757. doi: 10.1038/s41598-022-06821-4. Sci Rep. 2022. PMID: 35177781 Free PMC article. Clinical Trial.
-
Magnetic resonance imaging of the retina: A brief historical and future perspective.Saudi J Ophthalmol. 2011 Apr;25(2):137-43. doi: 10.1016/j.sjopt.2011.01.004. Epub 2011 Jan 26. Saudi J Ophthalmol. 2011. PMID: 23960915 Free PMC article.
-
Assessing the effects of ketorolac and acetazolamide on macular thickness by optical coherence tomography following cataract surgery.Int Ophthalmol. 2014 Jun;34(3):525-31. doi: 10.1007/s10792-013-9847-y. Int Ophthalmol. 2014. PMID: 24022643 Clinical Trial.